Post hoc analysis of ENCHANTED: in 3,206 patients with acute ischaemic stroke, body weight did not modify low- vs standard-dose alteplase effects (Pinteraction=0.60); in 4,458, weight <74 kg was associated with poor 90-day outcome (OR 1.41) and death but not sICH.
Secondary analysisn = 4,458
Ge et al. Body Weight in Relation to the Effectiveness of Intravenous Alteplase in Acute Ischemic Stroke: The ENCHANTED Trial